In early stage HCC, the CSPH group had a higher prevalence of hepatitis C and worse liver function markers (Child–Pugh grade, ALBI score, MELD score, prothrombin time, albumin concentration, and bilirubin concentration) as well as lower platelet count. This evidence concerns the gene F2 and hepatocellular carcinoma.